The anti-obesity action of chronic NP-1 administration might be mediated by TNFα, which is known to have anorectic actions in the hypothalamus and to regulate both Dmnt1 and Ucp1 expression in adipose tissues. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.